Published in J Leukoc Biol on March 07, 2014
Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment. Adv Cancer Res (2015) 1.25
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent. Ecancermedicalscience (2014) 0.87
Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to Mregs. Front Immunol (2014) 0.85
IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancer. Oncotarget (2015) 0.77
Addition of histamine to subcutaneously injected Plasmodium berghei sporozoites increases the parasite liver load and could facilitate whole-parasite vaccination. Malar J (2015) 0.76
The impact of ranitidine on monocyte responses in the context of solid tumors. Oncotarget (2016) 0.75
Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice. Oncoimmunology (2016) 0.75
Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 25.96
Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol (2012) 12.19
Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell (2012) 8.71
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother (2008) 6.55
The development of allergic inflammation. Nature (2008) 4.52
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol (2010) 3.86
Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev (2004) 3.63
Myeloid derived suppressor cells in human diseases. Int Immunopharmacol (2011) 2.43
Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med (2010) 2.30
A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med (2010) 2.06
Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. Blood (2011) 2.00
Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol (2003) 1.86
Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells. Int Immunol (2002) 1.81
Animal model of Nippostrongylus brasiliensis and Heligmosomoides polygyrus. Curr Protoc Immunol (2003) 1.70
The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Res (2009) 1.64
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood (2008) 1.63
Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol (1998) 1.59
A role for the hepatobiliary system in IgE-mediated intestinal inflammation in the rat. Clin Exp Allergy (1999) 1.45
Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. J Leukoc Biol (2009) 1.37
Myeloid-derived suppressor cells in parasitic infections. Eur J Immunol (2010) 1.36
IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J Immunol (2009) 1.35
Selective effector mechanisms for the expulsion of intestinal helminths. Parasite Immunol (1994) 1.32
The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol (2009) 1.29
Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest (1998) 1.20
Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J Immunol (2012) 1.15
Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol (2003) 1.11
A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. J Immunol (2010) 1.10
Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma. World J Gastroenterol (2012) 1.10
Mucosal mast cells and the allergic response against nematode parasites. Vet Immunol Immunopathol (1996) 1.09
Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthma. J Immunol (2012) 1.08
Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells. Biomed Res (2009) 1.07
Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness. Mucosal Immunol (2011) 1.04
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. PLoS One (2013) 1.00
ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch. J Immunol (2011) 0.99
Cimetidine suppresses lung tumor growth in mice through proapoptosis of myeloid-derived suppressor cells. Mol Immunol (2012) 0.95
Regulation of IL-13 production by histamine in cloned murine T helper type 2 cells. Int Immunopharmacol (2001) 0.90
Immunotherapeutic modulation of the suppressive liver and tumor microenvironments. Int Immunopharmacol (2011) 0.88
Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer. World J Gastroenterol (2012) 0.88
Histamine induces human beta-defensin-3 production in human keratinocytes. J Dermatol Sci (2009) 0.85
Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway. J Immunol (2012) 0.84
Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes. J Allergy Clin Immunol (1995) 0.83
Targeting c-kit in the therapy of mast cell disorders: current update. Eur J Pharmacol (2012) 0.82
Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion. Int Immunopharmacol (2011) 0.80
Etiopathogenesis and management of perennial allergic rhinitis: a state-of-the-art review. Treat Respir Med (2004) 0.80
Enhanced goblet cell hyperplasia in HDC knockout mice with allergic airway inflammation. Allergol Int (2009) 0.79
Histamine increases anti-CD3 induced IL-5 production of TH2-type T cells via histamine H2-receptors. Agents Actions (1994) 0.79
Histamine restricts cancer: nothing to sneeze at. Nat Med (2011) 0.78
Effects of anti-allergic drugs on intestinal mastocytosis and worm expulsion of rats infected with Neodiplostomum seoulense. Korean J Parasitol (2003) 0.78
Markers/parameters for the evaluation of natural resistance status of small ruminants against gastrointestinal nematodes. Animal (2012) 0.77
Effects of cetirizine on human eosinophil and neutrophil activation in vitro. Int Arch Allergy Appl Immunol (1991) 0.76